BORTEZOMIB BIOTECH 3.5mg powder for solution for infusion BIOTECH PHARMA LIMIT
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
letter B · page 27
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma
L01XX32 Antineoplastic and immunomodulating agents | Other antineoplastic agents
bortezomib Indicated for: multiple myeloma